Adjuvant intraperitoneal cisplatin therapy in patients with operated gastric carcinoma: results of a randomized trial
Related Experiment Videos
R Schiessel1, J Funovics, B Schick
11st Department of Surgery, University of Vienna, Austria.
Acta Medica Austriaca
|January 1, 1989
Abstract:
In a multicenter trial the efficacy of intraperitoneal administration of cisplatin after radical or palliative resection of gastric carcinoma with respect to overall survival was investigated. In 64 randomised patients, patients treated with intraperitoneal perfusion did not show a benefit in the overall survival after a median follow-up of 18 months.